Alitretinoin for the treatment of severe chronic hand eczema
- PMID: 25525339
- PMCID: PMC4270191
- DOI: 10.2147/PPA.S38830
Alitretinoin for the treatment of severe chronic hand eczema
Abstract
Chronic hand eczema is a common and often debilitating condition. Alitretinoin, a 9-cis-retinoic acid and pan-retinoic acid agonist, is a new and effective systemic treatment for chronic hand eczema, which provides another treatment option. A "clear" or "almost clear" response can be achieved in up to half of patients within a 24-week course of treatment. Even higher rates of remission can be obtained with a longer duration of treatment. Alitretinoin has a favorable overall profile of adverse effects; however, female patients who are at risk of becoming pregnant should follow a strict pregnancy-prevention program due to the teratogenic effects of this drug.
Keywords: CTCL; dermatitis; toctino.
References
-
- English J, Graham-Brown R, de Sica CA, Alexandroff AB. Everyday clinical experience of alitretinoin in the treatment of severe chronic hand eczema: seven case studies. Clin Exp Dermatol. 2011;(Suppl 36):1–2. - PubMed
-
- Alexandroff AB, Johnston GA. Medical management of contact dermatitis. G Ital Dermatol Venereol. 2009;144:537–540. - PubMed
-
- Diepgen TL, Andersen KE, Brandao FM, et al. Hand eczema classification: a cross-sectional, multicentre study of the aetiology and morphology of hand eczema. Br J Dermatol. 2009;160:353–358. - PubMed
-
- Castelain M, Assier H, Baeck M, et al. The European Standard Series and its additions: are they of any use in 2013? Eur J Dermatol. 2014 Jan-Feb;24(1):15–22. - PubMed
-
- Schalock PC, Dunnick CA, Nedorost S, et al. American contact dermatitis society core allergen series. Dermatitis. 2013 Jan-Feb;24(1):7–9. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
